Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

NCT00719602

Conditions: Blood-Borne Infections, Coinfection, Communicable Diseases, +17 more
Locations: University of North Carolina Lilongwe (12001) Lilongwe, Malawi

Makerere University - JHU Research Collaboration (30293) Kampala, Uganda

George Clinic CRS (30273) Lusaka, Zambia

View Trial Details

Completed

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study

NCT01679964

Conditions: Adverse Drug Reaction, Blood-Borne Infections, Chemically-Induced Disorders, +16 more
Locations: E-Da Hospital Kaohsiung, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

China Medical University Hospital Taichung, Taiwan

National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details

Completed

Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir

NCT02097108

Conditions: Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +16 more
Locations: PMU Salzburg Salzburg, Austria

AKH Wien Vienna, Austria

Ottto Wagner Spital Vienna, Austria

View Trial Details

Completed

Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort

NCT01740115

Conditions: Alcohol Drinking, Alcohol Use, Behavior, +23 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Fosamprenavir Expanded Access

NCT00240552

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Aarau, Switzerland

GSK Investigational Site Basel, Switzerland

GSK Investigational Site Bern, Switzerland

GSK Investigational Site Bruderholz, Switzerland

View Trial Details

Completed

Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

NCT01017536

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations: Aurum Institute Klerksdorp, North West, South Africa

View Trial Details

Completed

Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)

NCT00933595

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos

NCT01084421

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Detroit Hispanic Development Corporation (DHDC) Detroit, Michigan, United States

View Trial Details

Completed

Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

NCT00244803

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Johns Hopkins University, The Clinical Trials Unit Baltimore, Maryland, United States

View Trial Details

Completed

PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection

NCT00775424

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: University of Pennsylvania. Clinical Trials Unit Philadelphia, Pennsylvania, United States

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions